Your browser doesn't support javascript.
loading
Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic.
Souza, José Diogo S; Zuardi, Antonio W; Guimarães, Francisco S; Osório, Flávia de Lima; Loureiro, Sonia Regina; Campos, Alline Cristina; Hallak, Jaime E C; Dos Santos, Rafael G; Machado Silveira, Isabella Lara; Pereira-Lima, Karina; Pacheco, Julia Cozar; Ushirohira, Juliana Mayumi; Ferreira, Rafael Rinaldi; Costa, Karla Cristinne Mancini; Scomparin, Davi Silveira; Scarante, Franciele Franco; Pires-Dos-Santos, Isabela; Mechoulam, Raphael; Kapczinski, Flávio; Fonseca, Benedito A L; Esposito, Danillo L A; Andraus, Maristela Haddad; Crippa, José Alexandre S.
Afiliação
  • Souza JDS; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Zuardi AW; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Guimarães FS; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.
  • Osório FL; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.
  • Loureiro SR; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Campos AC; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Hallak JEC; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.
  • Dos Santos RG; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Machado Silveira IL; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Pereira-Lima K; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Pacheco JC; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.
  • Ushirohira JM; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Ferreira RR; National Institute for Science and Technology-Translational Medicine, Ribeirão Preto, Brazil.
  • Costa KCM; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Scomparin DS; University of Michigan Medical School, Ann Arbor, IN, United States.
  • Scarante FF; Department of Psychiatry, Federal University of São Paulo, São Paulo, São Paulo, Brazil.
  • Pires-Dos-Santos I; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Mechoulam R; Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Kapczinski F; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Fonseca BAL; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Esposito DLA; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Andraus MH; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Crippa JAS; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Front Pharmacol ; 13: 856846, 2022.
Article em En | MEDLINE | ID: mdl-36263136

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article